FK866 compromises mitochondrial metabolism and adaptive stress responses in cultured cardiomyocytes.

Biochem Pharmacol 2015 Nov 20;98(1):92-101. Epub 2015 Aug 20.

Advanced Center for Chronic Disease (ACCDiS) and Center for Molecular Studies of the Cell (CEMC), Facultad de Ciencias Químicas y Farmacéuticas & Facultad de Medicina, Universidad de Chile, Santiago, Chile; Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, Chile; Department of Internal Medicine (Cardiology Division), University of Texas Southwestern Medical Center, Dallas, Texas, USA. Electronic address:

Aim: FK866 is an inhibitor of the NAD(+) synthesis rate-limiting enzyme nicotinamide phosphoribosyltransferase (NAMPT). Using FK866 to target NAD(+) synthesis has been proposed as a treatment for inflammatory diseases and cancer. However, use of FK866 may pose cardiovascular risks, as NAMPT expression is decreased in various cardiomyopathies, with low NAD(+) levels playing an important role in cardiovascular disease progression. In addition, low NAD(+) levels are associated with cardiovascular risk conditions such as aging, dyslipidemia, and type II diabetes mellitus. The aim of this work was to study the effects of FK866-induced NAD(+) depletion on mitochondrial metabolism and adaptive stress responses in cardiomyocytes.

Methods And Results: FK866 was used to deplete NAD(+) levels in cultured rat cardiomyocytes. Cell viability, mitochondrial metabolism, and adaptive responses to insulin, norepinephrine, and H2O2 were assessed in cardiomyocytes. The drop in NAD(+) induced by FK866 decreased mitochondrial metabolism without changing cell viability. Insulin-stimulated Akt phosphorylation, glucose uptake, and H2O2-survival were compromised by FK866. Glycolytic gene transcription was increased, whereas cardiomyocyte hypertrophy induced by norepinephrine was prevented. Restoring NAD(+) levels via nicotinamide mononucleotide administration reestablished mitochondrial metabolism and adaptive stress responses.

Conclusion: This work shows that FK866 compromises mitochondrial metabolism and the adaptive response of cardiomyocytes to norepinephrine, H2O2, and insulin.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2015.08.097DOI Listing
November 2015
9 Reads

Publication Analysis

Top Keywords

mitochondrial metabolism
24
metabolism adaptive
20
nad+ levels
16
adaptive stress
12
stress responses
8
fk866
8
norepinephrine h2o2
8
nad+ synthesis
8
nad+
8
low nad+
8
cell viability
8
fk866 compromises
8
compromises mitochondrial
8
metabolism
6
mitochondrial
6
adaptive
5
insulin-stimulated akt
4
conditions aging
4
akt phosphorylation
4
cardiovascular risk
4

Similar Publications